Selena Gomez, founder of Rare Impact Fund

About Us Our Founder

Recording artist, actress, producer, entrepreneur, and philanthropist, Selena Gomez has been a leading voice in mental health for over a decade. With unflinching honesty, she shared her personal struggles in the 2022 film My Mind & Me, and consciously works to destigmatize the subject by discussing her mental health journey openly in the media. Selena’s experiences inspired her to establish her beauty brand, Rare Beauty, as a safe, welcoming community for young people everywhere. With The Rare Impact Fund, she aims to create real and lasting change.

As part of this effort, 1% of all Rare Beauty sales are donated to the Rare Impact Fund. In addition, the Rare Impact Fund raises funds from philanthropic foundations, individuals, corporate partners, and the community.

What We Do The Rare Impact Fund is:

Mobilizing $100 million in philanthropic dollars to distribute to trusted organizations that align with our vision and mission
Sourcing and vetting non-profit partners in mental health to reach more young people and inform the field
Connecting our donor community to a growing cohort of mental health organizations to increase social capital

Raising awareness and de-stigmatizing youth mental health

To Hydroxychloroquine Online Visit Our Pharmacy ↓




Potential Side Effects: Assessing the Risk-benefit Ratio



Furthermore, it is imperative to address the issue of misinformation surrounding hydroxychloroquine. However, others have emphasized the lack of conclusive evidence and the need for further research to determine its effectiveness. Regulatory bodies and health organizations faced immense pressure to provide guidance on hydroxychloroquine's use, leading to inconsistent recommendations and further exacerbating the controversy. Hydroxychloroquine operates by modulating the immune system and reducing inflammation, making it a valuable tool in combating various diseases. Among the proposed solutions, hydroxychloroquine (HCQ), a drug commonly used for malaria and certain autoimmune disorders, quickly gained attention. Evaluating the Research FindingsResearch studies have been conducted to analyze the efficacy of hydroxychloroquine in preventing lupus flares. Despite a lack of rigorous evidence, preliminary studies have suggested potential benefits in reducing symptoms and shortening the duration of illness.



Global Variations in Hydroxychloroquine Usage



One of the prevailing myths is that hydroxychloroquine is a cure-all for numerous ailments, including lupus. As a compound medication, it has shown remarkable efficacy in maintaining remission and enhancing the quality of life for lupus patients. It works by interfering with the malaria parasite's ability to process hemoglobin, essentially starving the parasite of the nutrients it needs to survive. While some studies have suggested potential benefits in treating COVID-19, others have raised concerns about its efficacy and safety. The urgency of timely data validation became a focal point for decision-makers. Since the early 17th century, quinine has been utilized for its medicinal properties against malaria, a life-threatening disease caused by parasites transmitted through the bite of infected mosquitoes. Hydroxychloroquine has been the subject of numerous clinical applications and studies.



Ethical Considerations: Prioritizing Patient Safety and Transparency



This comp, much like a vigilant guard, stands at the cellular gateway, challenging viruses that seek entry. Before considering hydroxychloroquine as a treatment option for autoimmune diseases, it is important to understand its potential side effects. Food and Drug Administration (FDA), after initially granting emergency use authorization for hydroxychloroquine in specific hospital settings, later revoked it due to concerns over its effectiveness and potential risks. As the world grappled with the Covid-19 pandemic, hydroxychloroquine emerged as a potential treatment, sparking a flurry of clinical trials. Individuals with pre-existing retinal disease may face a heightened risk of retinopathy, a serious eye condition that can lead to vision loss when using hydroxychloroquine over long periods. Headlines often amplify sensational claims, influencing audiences before detailed scientific findings emerge. Patients prescribed hydroxychloroquine often report improved quality of life and increased functionality in managing their autoimmune disorders, highlighting its significance in the realm of autoimmune therapy.



Monitoring and Adjusting Dosage as Necessary



The experiences of these medical professionals were as varied as the patients they treated. However, as more research has been conducted, the effectiveness of hydroxychloroquine in treating COVID-19 has come under scrutiny. Despite rigorous trials, the 'silver bullet' expectations often fall short, leading to a tug-of-war between hope, science, and skepticisim. Precautions should include avoidance of concurrent use of other medications known to interact with hydroxychloroquine and to watch for potential drug-drug interactions. This promising treatment option offers hope to those suffering from conditions such as rheumatoid arthritis, lupus, and Sjögren's syndrome. However, it was the emergence of the Covid-19 pandemic that brought hydroxychloroquine into the spotlight. As researchers continue to delve into the realm of hydroxychloroquine's efficacy, further data and analysis are required to draw conclusive evidence on its role in tackling the pandemic.



Understanding Hydroxychloroquine Treatment



Despite its proven efficacy in treating certain medical conditions, healthcare professionals must carefully weigh the benefits against the risks and closely monitor patients who are prescribed this medication. Regular monitoring of the patient's vision and a baseline eye examination are crucial due to the risk of retinopathy. This politicization of potential treatments created an environment where scientific data were at times overshadowed by political endorsements or condemnations, potentially affecting funding for research, the direction of scientific inquiries, and the trust in health authorities and the scientific community at large. Some early studies suggested that it could be effective in treating the disease, particularly when used in combination with other medications. . Scripts involving hydroxychloroquine might soon become a staple for managing these complex ailments. It is important to note that these risks may increase when hydroxychloroquine is taken in higher doses or used for long-term treatment.



Research Findings and Clinical Trials



The drug's utility in autoimmune diseases is attributed to its potential to diminish antibody production, quell acute flares, and stabilize disease progression over time. As the pandemic unfolded, various outlets portrayed hydroxychloroquine with starkly contrasting views, ranging from a potential cure to a controversial remedy. Enthusiastic reports and anecdotal claims of its effectiveness propagated rapidly, overshadowing the preliminary nature of the studies behind them. Continued research and clinical trials will undoubtedly shed more light on the full scope of hydroxychloroquine's medical impact, allowing for informed decisions on how it can best be utilized in various medical contexts. By altering the pH, hydroxychloroquine disrupts the function of these organelles. While some studies have shown promise, others have raised concerns about its efficacy and safety. One prevalent myth suggests that it is universally effective against all viral infections, including COVID-19.



Media's Role in Spreading Misinformation



Initially garnering widespread attention, this Comp emerged as a potential candidate against the virus, sparking global discussions. The controversy began as preliminary studies reached conflicting conclusions, some indicating a benefit, others showing no effect, and some even suggesting potential harm due to its side effects, such as cardiac arrhythmias. Hydroxychloroquine dosage is determined based on various factors like patient weight and medical condition. However, it is important to approach these findings with caution, as there are still ongoing debates regarding the overall effectiveness of hydroxychloroquine in treating Covid-19. It acts by interfering with the function of lysosomes within cells, which are responsible for breaking down waste materials and regulating cellular processes. Early studies demonstrated some promise, fueling a global rush to secure the compound medication. The controversy surrounding hydroxychloroquine grew as conflicting studies emerged, creating confusion among healthcare professionals and the general public.



Potential Side Effects and Misconceptions



As researchers scrambled to understand the virus and evaluate treatment options, hydroxychloroquine's role in the fight against COVID-19 became as much a matter of science as it was a reflection of the tumultuous socio-political climate that enveloped global health discourse. Different studies and opinions have emerged, leading to contrasting views on its efficacy and safety. In recent years, it has gained considerable attention as a potential treatment for various conditions. However, subsequent rigorous clinical trials yielded mixed results, with some showing no significant efficacy and others indicating potential harm, particularly concerning cardiac issues. Controversies surrounding the use of hydroxychloroquine have sparked intense debate within the medical community and beyond. With its expanded use, hydroxychloroquine was repurposed and became a cornerstone treatment for autoimmune diseases, most notably systemic lupus erythematosus and rheumatoid arthritis. The incident underscored the need for coordinated communication strategies that clarify the distinction between potential treatments under investigation and those proven to be effective.



Controversies and Ongoing Debates



These scientific endorsements have solidified hydroxychloroquine's reputation as a cornerstone in managing chronic autoimmune diseases. These effects disrupt the function of antigen-presenting cells and consequentially, interfere with pathogenic processes, including inflammation. Critics argue that the existing evidence is insufficient to support its widespread use, while proponents advocate for further research and clinical trials. Common side effects include gastrointestinal symptoms such as nausea, vomiting, and diarrhea. It is important for healthcare providers to consider these variables when prescribing hydroxychloroquine to ensure optimal therapeutic outcomes and minimize the risk of suboptimal treatment due to absorption issues. Hydroxychloroquine has become an essential treatment option for autoimmune diseases such as lupus and rheumatoid arthritis (RA). A key player in the repertoire is Remdesivir, an antiviral that has gained significant traction.



Potential Antiviral Activity



Unraveling the Hydroxychloroquine Hype: Examining the Facts. The desire for an immediate solution saw hydroxychloroquine thrust into the spotlight before clinical studies offered conclusive evidence. By reducing joint pain and inflammation, it allows patients to regain flexibility and improve quality of life. However, it is important to note that the antiviral activity of hydroxychloroquine is highly dependent on the specific virus and the stage of viral replication. Hydroxychloroquine has seen varying levels of utilization and acceptance globally, being more than just a medication in some regions; it's a staple in the fight against prevalent diseases. Therefore, regular ophthalmologic examinations are recommended for individuals on prolonged treatment. The use of hydroxychloroquine during the COVID-19 pandemic prompted significant shifts in global health protocols.



Buy Imuran No Prescription
Buy Aricept Online
Semaglutide Without Insurance

Driving more dollars to an underfunded field

Accord­ing to recent data, 62% of young people who have struggled with their mental health are not getting the complete care they need.

Recent data also tells us that global governments are allocating only 2% of their budgets toward mental health, and only 34% of responding countries indicated that their financial needs had been met.

As global governments come up short, private donations are proving to be essential. Yet just 0.5% of global health philanthropic spend went to mental health in 2021, according to WHO.

The Rare Impact Fund bridges the gap between donors and non-profits to generate much-needed financial support for mental health. Chief among priorities is supporting non-profits providing services to underrepresented populations as we recognize that mental health disparities among young people who are Black, Indigenous, and/or people of color (BIPOC), and LGBTQ+. are severely under resourced. The Rare Impact Fund portfolio is currently 40% BIPOC-led; globally, 20% of our non-profit partners are managed by leaders of color.

The Rare Impact Fund is shifting donor attention to non-profits making a tangible difference in the mental health space, ultimately changing the way they allocate funding.

Expanding access to mental health resources through data

Access to care is a chal­lenge for Gen Z, too. A 2022 Kaiser Fam­i­ly Foun­da­tion sur­vey found that almost half (47%) of young adults ages 18 to 29 did not get men­tal health care in the past year when they thought they might need it, with cost cit­ed among the top bar­ri­ers.

The Rare Impact Fund collects and analyzes quantitative and qualitative data from our non-profit partners to inform our approach to delivering grants and resources.

We monitor the progress of our non-profit partners to assess ways to optimize their impact. This approach to measurement provides donors and prospective partners insight into the most powerful ways to deploy funding. Our aim is to continue expanding access to youth mental health resources by stretching each dollar to its maximum potential.